Considering the above evidence, a variety of signaling networks are involved in CP resistance by EMT induction, and studies have investigated the ability of various compounds and molecular pathways to inhibit the EMT mechanism that may sensitize cancer cells to chemotherapy. This evidence concerns the gene CP and cancer.